Beam Therapeutics Inc (BEAM) with a beta value of 1.90 appears to be a promising investment opportunity.
Beam Therapeutics Inc (NASDAQ: BEAM) kicked off on Monday, up 3.38% from the previous trading day, before settling in for the closing price of $27.37.